Patient Versus Physician Perspective in the Management of Chronic Myeloid Leukemia During Treatment with Tyrosine Kinase Inhibitors

被引：0

作者：

Hong Chen

Yan Wen

Yun Zeng

Lie Lin

Bihong Sun

Hongqian Zhu

Huiqing He

Xiaotao Wang

Waiyi Zou

Caifeng Zheng

Liling Zheng

Jinxiong Huang

Liping Pang

Jixian Huang

Yuming Zhang

Haiqing Lin

Zelin Liu

Wanshou Zhu

Qiang Wang

Xuan Zhou

Xiaoli Liu

Hong Qu

Zhenfang Liu

Xin Du

Na Xu

机构：

[1] Nanfang Hospital,Department of Hematology

[2] Southern Medical University,Department of Hematology

[3] Yunnan Hematology Hospital,Department of Hematology

[4] First People’ Hospital of Yunnan,Department of Hematology

[5] Affiliated Hospital of Kunming University of Science and Technology,Department of Hematology

[6] First Affiliated Hospital of Kunming Medical University,Department of Hematology

[7] Hematology Research Center of Yunnan Province,Department of Hematology

[8] Hainan General Hospital,Department of Hematology

[9] People’s Hospital of Guangxi Zhuang Autonomous Region,Department of Hematology

[10] Guizhou Provincial People’s Hospital,Department of Hematology

[11] Zhongshan People’s Hospital,Department of Hematology

[12] Guilin Medical University Affiliated Hospital,Department of Hematology

[13] The First Affiliated Hospital,Department of Hematology

[14] Sun Yat-Sen University,Department of Hematology

[15] Shenzhen Bao An People’s Hospital,Department of Hematology

[16] The Second People’s Hospital of Guangdong Province,Department of Hematology

[17] Liuzhou People’s Hospital,Department of Hematology

[18] Peking University Shenzhen Hospital,Department of Hematology

[19] Yue Bei People’s Hospital,Department of Hematology

[20] Shantou University Medical College,Department of Hematology

[21] Affiliated Hospital of Guangdong Medical University,Department of Hematology and Shenzhen Bone Marrow Transplantation Public Service Platform

[22] Shenzhen People’s Hospital,undefined

[23] Second Clinical Medical College of Jinan University,undefined

[24] First Affiliated Hospital of Southern University of Science and Technology,undefined

[25] Huazhong University of Science and Technology Union Shenzhen Hospital,undefined

[26] Gaozhou People’s Hospital,undefined

[27] Panyu Central Hospital,undefined

[28] The First Affiliated Hospital of Guangxi Medical University,undefined

[29] The First Affiliated Hospital of Shenzhen University,undefined

[30] Shenzhen Second People’s Hospital,undefined

[31] Shenzhen University School of Medicine,undefined

来源：

Oncology and Therapy | 2024年 / 12卷

关键词：

Chronic myeloid leukemia; Patient; Physician; Quality of life; Discrepancies;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：131 / 145

页数：14

共 50 条

[21] Use of tyrosine kinase inhibitors in a patient with Brugada syndrome and chronic myeloid leukemia
Nicola Sgherza
Antonella Vita Russo Rossi
Paolo Colonna
Paola Carluccio
Mario Delia
Giorgina Specchia
International Journal of Hematology, 2013, 98 : 483 - 486
[22] Use of tyrosine kinase inhibitors in a patient with Brugada syndrome and chronic myeloid leukemia
Sgherza, Nicola
Rossi, Antonella Vita Russo
Colonna, Paolo
Carluccio, Paola
Delia, Mario
Specchia, Giorgina
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (04) : 483 - 486
[23] Genetics and tyrosine kinase inhibitors of chronic myeloid leukemia
Ganguly, Bani Bandana
Kadam, Nitin N.
NUCLEUS-INDIA, 2019, 62 (02): : 155 - 164
[24] Dual tyrosine kinase inhibitors in chronic myeloid leukemia
Martinelli, G
Soverini, S
Rosti, G
Baccarani, M
LEUKEMIA, 2005, 19 (11) : 1872 - 1879
[25] Preliminary Exploration of Patient Perspectives on Tyrosine Kinase Inhibitors for the Treatment of Chronic-Phase Chronic Myeloid Leukemia
Mason, Bradley
Mamolo, Carla M.
Johnson, Chloe
Viqueira, Andrea
Gater, Adam
Russell-Smith, Alexander
Tatlock, Sophi
Shah, Richa
Cappelleri, Joseph C.
BLOOD, 2019, 134
[26] Resistance to tyrosine kinase inhibitors in chronic myeloid leukemia
Lion, T.
EUROPEAN JOURNAL OF CANCER, 2011, 47 : S3 - S3
[27] New tyrosine kinase inhibitors in chronic myeloid leukemia
Martinelli, Giovanni
Soverini, Simona
Rosti, Gianantonio
Cilloni, Daniela
Baccarani, Michele
HAEMATOLOGICA, 2005, 90 (04) : 534 - 541
[28] Dual tyrosine kinase inhibitors in chronic myeloid leukemia
G Martinelli
S Soverini
G Rosti
M Baccarani
Leukemia, 2005, 19 : 1872 - 1879
[29] Genetics and tyrosine kinase inhibitors of chronic myeloid leukemia
Bani Bandana Ganguly
Nitin N. Kadam
The Nucleus, 2019, 62 : 155 - 164
[30] New tyrosine kinase inhibitors in chronic myeloid leukemia
Kantarjian, Hagop
Cortes, Jorge
CANCER INVESTIGATION, 2007, 25 : 41 - 43

← 1 2 3 4 5 →